Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
VitaDAO is a decentralized collective funding early stage longevity research. | ||||||
Allogene Therapeutics is a San Francisco, California-based biotechnology company specializing in the development of allogeneic CAR T("AlloCAR TTM") therapies for cancer. | ||||||
Cortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California. | ||||||
A molecular diagnostics company developing novel blood-based early detection and disease monitoring tests based on analyzing circulating cell-free messenger RNA (cf-mRNA) in blood samples to monitor organ function. | ||||||
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that takes a precision medicine approach in acquiring, developing and commercializing medicines for patient populations that are suffering from rare diseases and cancer. | ||||||
A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases. | ||||||
FoRx Therapeutics is a Basel-based biotechnology company developing a drug discovery platform for cancer drugs. | ||||||
Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics. | ||||||
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients. | ||||||
Imara is a Cambridge, Massachusetts-based biotechnology company. | ||||||
Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases. | ||||||
ESSA Pharma is developing treatments for prostate cancer. | ||||||
Trillium Therapeutics is a biotechnology company developing cancer immunotherapies. | ||||||
NextCure is an immune Therapies founded by Lieping Chen. | ||||||
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs. | ||||||
A company developing therapies for cancer and immune disorders | ||||||
Vivet Therapeutics is a gene Therapy for Orphan Diseases founded in 2016 by Jean-Philippe Combal. | ||||||
Ue Lifesciences is a Philadelphia-based company founded in 2009 by Mihir Shah, Bhaumik Sanghvi and Matt Campisi. | ||||||
AnTolRx is a nanoparticle-based Therapies. | ||||||
Enodia Therapeutics is a small-molecule platform for targeted protein degradation founded in 2025. | ||||||
ALS targeting drugs | ||||||
Strata is a marketing company founded in 1995. |